企业信息
17
  • 入驻时间: 2008-08-20
  • 联系人:客户经理
  • 电话:400-968-7988
  • 联系时,请说明易展网看到的
  • Email:fuwu@bioleaf.com
产品详情
  • 产品名称:Mouse Anti-SARS Coronavirus Nucleoprotein Antibody (3851)

  • 产品型号:
  • 产品厂商:其它品牌
  • 产品价格:196.88
  • 折扣价格:0
  • 产品文档:
你添加了1件商品 查看购物车
简单介绍:

Mouse monoclonal antibody specific for SARS Coronavirus nucleoprotein (3851)

详情介绍:

SARS Coronavirus nucleoprotein antibody – clone 3851

SARS Coronavirus nucleoprotein antibody is specific for the nucleocapsid protein of Severe acute respiratory syndrome Coronavirus (SARS-CoV). SARS Coronavirus nucleoprotein antibody does not react with human Coronavirus 229E and OC43, feline FIP-1, FIP-2, canine Coronavirus TGEV or mouse hepatitis virus.

Severe acute respiratory syndrome (SARS) is a lower respiratory tract illness that was first reported in patients from the Guandong Province of China in November 2002. The causative agent, which was previously unknown, was isolated in 2003 and named as SARS coronavirus (SARS-CoV). The SARS coronavirus is an enveloped, single-stranded, positive RNA virus of the family Coronoviridae (NCBI) The virus is thought to have a zoonotic origin, with the horseshoe bat being the primary natural reservoir, but this has not been confirmed. Mammals, including the palm civet, may act as intermediate hosts.

In 2003, the SARS coronavirus spread rapidly and affected over 8,000 people in 26 countries. The rapid spread of SARS-CoV is thought to be due to person-to-person transmission of the virus via aerosol droplets or close contact with infected individuals. Since the end of the SARS epidemic, cases of SARS have only occurred in laboratory workers that have been accidently infected (WHO).

The symptoms of SARS infection are like influenza and include fever, malaise, muscle pain, headache, diarrhoea and shivering. Clinical symptoms may also include coughing and shortness of breath. Respiratory distress may rapidly develop in some patients, resulting in death. SARS disease has a high rate of mortality and resulted in 774 deaths during the first epidemic in 2003.

Currently, no licenced vaccine is available for the prevention of SARS infection. SARS continues to be of global health concern due to the rapid spread of the virus, the high mortality rate and the fears of a future SARS outbreak.

References

NCBI: Severe Acute Respiratory Syndrome Coronovirus

World Health Organization: SARS (Severe Acute Respiratory Syndrome)


Product datasheet

标题:
内容:
联系人:
联系电话:
Email:
公司名称:
联系地址:
 
 
注:1.可以使用快捷键Alt+S或Ctrl+Enter发送信息!
2.如有必要,请您留下您的详细联系方式!
相关文章

沪公网安备 31011202007337号